Intelligence Β· Clinical Pipeline

RIGEL PHARMACEUTICALS Pipeline

All ClinicalTrials.gov programs at RIGEL PHARMACEUTICALS β€” phase, modality, and trial IDs.

Programs
3

Quick answer

RIGEL PHARMACEUTICALS has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Fostamatinib

    RIGEL PHARMACEUTICALS INC

    Covid19

    phase 3 small molecule completed

    1 trial
  2. Fostamatinib disodium

    RIGEL PHARMACEUTICALS INC

    Immune Thrombocytopenic Purpura

    phase 3 small molecule completed

    3 trials
  3. Fostamatinib disodium

    RIGEL PHARMACEUTICALS INC

    Warm Antibody Autoimmune Hemolytic Anemia

    phase 3 small molecule active

    2 trials

Frequently asked questions

How many pipeline programs does RIGEL PHARMACEUTICALS have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs